OTC Markets OTCPK - Delayed Quote USD

Cardiac Biotech Solutions Inc. (CBSC)

0.0440
0.0000
(0.00%)
At close: June 12 at 8:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
60.7180
135.0550
82.4050
75.5760
32.4380
Cost of Revenue
0
0
42.2390
149.2410
9.8090
Gross Profit
60.7180
135.0550
40.1660
-73.6650
22.6290
Operating Expense
1,508.0710
1,730.7560
2,142.0790
1,797.1580
2,965.2430
Operating Income
-1,447.3530
-1,595.7010
-2,101.9130
-1,870.8230
-2,942.6140
Net Non Operating Interest Income Expense
-15.1840
-5.2920
-4.6640
-1,543.8130
-344.3000
Other Income Expense
37.3290
-29.2500
--
-2,927.6400
-1,040.7680
Pretax Income
-1,425.2080
-1,630.2430
-2,106.5770
-6,342.2760
-4,327.6820
Net Income Common Stockholders
-1,425.2080
-1,630.2430
-2,106.5770
-6,342.2760
-4,327.6820
Diluted NI Available to Com Stockholders
-1,425.2080
-1,630.2430
-2,106.5770
-6,342.2760
-4,327.6820
Basic EPS
-0.00
-0.01
-0.02
-0.07
-0.06
Diluted EPS
-0.00
-0.01
-0.02
-0.07
-0.06
Basic Average Shares
151,634.4340
139,592.4590
119,146.3330
91,224.6860
77,917.9620
Diluted Average Shares
151,634.4340
139,592.4590
119,146.3330
91,224.6860
77,917.9620
Total Operating Income as Reported
-1,447.3530
-1,595.7010
-2,101.9130
-1,870.8230
-2,942.6140
Total Expenses
1,508.0710
1,730.7560
2,184.3180
1,946.3990
2,975.0520
Net Income from Continuing & Discontinued Operation
-1,425.2080
-1,630.2430
-2,106.5770
-6,342.2760
-4,327.6820
Normalized Income
-1,462.5370
-1,600.9930
-2,106.5770
-3,414.6360
-3,286.9140
Interest Income
--
0
0.5420
0
--
Interest Expense
15.1840
5.2920
5.2060
1,543.8130
344.3000
Net Interest Income
-15.1840
-5.2920
-4.6640
-1,543.8130
-344.3000
EBIT
-1,410.0240
-1,624.9510
-2,101.3710
-4,798.4630
-3,983.3820
EBITDA
-1,410.0240
-1,624.9510
-2,101.3710
-4,797.8520
-3,976.6290
Reconciled Cost of Revenue
0
0
42.2390
149.2410
9.8090
Reconciled Depreciation
--
--
0
0.6110
6.7530
Net Income from Continuing Operation Net Minority Interest
-1,425.2080
-1,630.2430
-2,106.5770
-6,342.2760
-4,327.6820
Total Unusual Items Excluding Goodwill
37.3290
-29.2500
0
-2,927.6400
-1,040.7680
Total Unusual Items
37.3290
-29.2500
0
-2,927.6400
-1,040.7680
Normalized EBITDA
-1,447.3530
-1,595.7010
-2,101.3710
-1,870.2120
-2,935.8610
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
3/31/2021 - 2/16/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HBI.MU Harvard Bioscience Inc
0.4380
-0.45%
 
S5U5.DU Safilo Group SpA
0.8180
-3.08%
 
GXI.BE Gerresheimer AG
47.06
-1.47%
 
SAFLF Safilo Group S.p.A.
0.7600
0.00%
 
ECIA Encision Inc.
0.3200
-13.51%
 
WHSI Wearable Health Solutions, Inc.
0.0001
0.00%
 
IMTH Innovative MedTech, Inc.
0.1390
+32.25%
 
1ISRG.MI Intuitive Surgical, Inc.
446.20
+0.07%
 
6699.HK Angelalign Technology Inc.
57.650
-1.71%
 
SYNSAM.ST Synsam AB (publ)
53.70
-0.74%